Helen Mosnier-Pudar

The Type and the Position of <i>HNF1A</i> Mutation Modulate Age at Diagnosis of Diabetes in Patients with Maturity-Onset Diabetes of the Young (MODY)-3

Christine Bellanné-Chantelot, Claire Carette, Jean‐Pierre Riveline et al. · Diabetes · 2007 · 190 citations · Full text

Midnight Salivary Cortisol for the Initial Diagnosis of Cushing’s Syndrome of Various Causes

Maria Yaneva, Helen Mosnier-Pudar, Marie-Annick Dugué et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 180 citations · Full text

Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial

Manfred Ballmann, D. Hubert, B.M. Assael et al. · The Lancet Diabetes & Endocrinology · 2017 · 66 citations

Metabolic Syndrome, Repaglinide Versus Insulin, Diabetes Management +7

Renal Involvement in Cystic Fibrosis

Yasmina Yahiaoui, Mathieu Jablonski, D. Hubert et al. · Clinical Journal of the American Society of Nephrology · 2009 · 61 citations · Full text

Comparison of Once- Versus Twice-Daily Administration of Insulin Detemir, Used With Mealtime Insulin Aspart, in Basal-Bolus Therapy for Type 1 Diabetes

Jean‐Pierre Le Floch, Marc Lévy, Helen Mosnier-Pudar et al. · Diabetes Care · 2008 · 44 citations · Full text